Orchestra BioMed Holdings (OBIO) Receivables - Net (2022 - 2026)
Orchestra BioMed Holdings (OBIO) posted quarterly Receivables - Net of $84000.0 for Q1 2026, down 5.62% year-over-year from $89000.0 in Q1 2025, and down 11.58% quarter-over-quarter from $95000.0 in Q4 2025.
Powered by 
Analysis
Orchestra BioMed Holdings (OBIO) Receivables - Net (2022 - 2026) Analysis & Trends
Orchestra BioMed Holdings (OBIO) has reported Receivables - Net for 5 consecutive years, with $84000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Receivables - Net fell 5.62% year-over-year to $84000.0; the TTM figure through Mar 2026 stood at $84000.0 (down 5.62% YoY), while the FY2025 annual figure was $95000.0, up 3.26% from the prior year.
- Receivables - Net declined to $84000.0 in Q1 2026 per OBIO's latest filing, from $95000.0 in the prior quarter.
- Across five years, Receivables - Net topped out at $171000.0 in Q2 2023 and bottomed at $52000.0 in Q3 2025.
- Historically, Receivables - Net has averaged $91785.7 across 5 years, with a median of $87500.0 in 2023.
- Annual changes were most pronounced in 2024 — Receivables - Net soared 33.72% — and 2025, when it tumbled 54.78%.
- Orchestra BioMed Holdings' Receivables - Net stood at $96000.0 in 2022, then advanced by 3.12% to $99000.0 in 2023, then retreated by 7.07% to $92000.0 in 2024, then climbed by 3.26% to $95000.0 in 2025, then retreated by 11.58% to $84000.0 in 2026.
- Business Quant data shows OBIO's Receivables - Net at $84000.0 in Q1 2026, $95000.0 in Q4 2025, and $52000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Orchestra BioMed Holdings | 322.25 Mn | 127.72 Mn | 63,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 51,000.00 |
| Mar 31, 2026 | 84,000.00 |
| Dec 31, 2025 | 95,000.00 |
| Sep 30, 2025 | 52,000.00 |
| Jun 30, 2025 | 83,000.00 |
| Mar 31, 2025 | 89,000.00 |
| Dec 31, 2024 | 92,000.00 |
| Sep 30, 2024 | 115,000.00 |
| Jun 30, 2024 | 80,000.00 |
| Mar 31, 2024 | 67,000.00 |
| Dec 31, 2023 | 99,000.00 |
| Sep 30, 2023 | 86,000.00 |
| Jun 30, 2023 | 171,000.00 |
| Mar 31, 2023 | 76,000.00 |
| Dec 31, 2022 | 96,000.00 |